MCP
WGS icon

Meridiem Capital Partners’s GeneDx Holdings WGS Stock Holding History

Meridiem Capital Partners’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.57M Buy
55,585
+34,778
+167% +$3.17M 0.23% 63
2025
Q4 		$2.71M Buy
+20,807
New +$2.86M 0.16% 68
2025
Q2 		– Sell
-19,271
Closed -$1.71M – 98
2025
Q1 		$1.71M Buy
+19,271
New +$1.67M 0.18% 55

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Meridiem Capital Partners's WGS Position: Q1 2026 in Review

Meridiem Capital Partners increased its GeneDx Holdings (WGS) stake by 167% in Q1 2026, buying an estimated $3.17M and bringing the position to 55,585 shares worth $3.57M. The position accounts for 0.23% of the portfolio, ranked #63.

Meridiem Capital Partners first reported a position in WGS in Q1 2025 and has held it in 3 quarters since. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Meridiem Capital Partners held 55,585 shares of GeneDx Holdings worth $3.57M as of Q1 2026.
  • Meridiem Capital Partners bought 34,778 GeneDx Holdings shares in Q1 2026, an estimated $3.17M.
  • GeneDx Holdings made up 0.23% of Meridiem Capital Partners's portfolio in Q1 2026, its #63 holding.
  • Meridiem Capital Partners first reported a position in GeneDx Holdings in Q1 2025 and has held it in 3 quarters since.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Meridiem Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.